title: Prosthetic valvular hemolysis: a potential pitfall in the routine use of serum lactate dehydrogenase as tumor marker in patients with germ cell testicular tumors.
authors.affiliation: Department of Urology, Meir Medical Center, Kfar Saba, Israel. leibovitchi@clalit.org.il
authors.forename: Ilan
authors.initials: I
authors.lastname: Leibovitch
authors.forename: Michael
authors.initials: M
authors.lastname: Veinreb
authors.forename: Itay
authors.initials: I
authors.lastname: Sterenberg
authors.forename: Reuben
authors.initials: R
authors.lastname: Alkalay
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006461:Hemolysis; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000473:pathology*; D011379:Prognosis; D013736:Testicular Neoplasms / Q000097:blood / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor; D007770:L-Lactate Dehydrogenase